about
Discoverers of quinineA structurally distinct human mycoplasma protein that generically blocks antigen-antibody unionStamp vignette on medical science. Robert F. Curl Jr-Nobel Laureate in ChemistryAbbie Lathrop, the "mouse woman of Granby": rodent fancier and accidental genetics pioneerAppraisal of immunoglobulin free light chain as a marker of responseWalter Hess—Nobel Prize for work on the brainCriteria for diagnosis, staging, risk stratification and response assessment of multiple myelomaImmunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaMonoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyPrognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemMultiple myelomaSerum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceImmunoglobulin free light chains and solitary plasmacytoma of boneAmerican Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic CePrognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaHenry Bence Jones--physician, chemist, scientist and biographer: a man for all seasonsGeorge R. Minot--Nobel Prize for the treatment of pernicious anemiaAmyloidosis: a convoluted storyWorsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agentsDiagnosis and management of Waldenstrom's macroglobulinemiaControl of systemic capillary leak syndrome with aminophylline and terbutalineGene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaEpidemiology of the plasma-cell disorders6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significanceAna Aslan--founder of the first Institute of GeriatricsDiagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelinesArgentinian paleontologist contributes to the understanding of humans and the environmentLudwik Rydygier--famous Polish surgeonInhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormalityMu-heavy chain disease: presentation as a benign monoclonal gammopathyFrederick Soddy--pioneer in radioactivityMaintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyImpact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.Early philosopher of medical etiology.Stamp vignette on medical science. Francis S. Collins--Human Genome Project.Alexander Borodin.Primary localized amyloidosis of the urinary bladder: a case series of 31 patients.Charles Townes—nobel laureate for maser-laser work.Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.
P50
Q21032528-6640DE93-B597-4CD4-BE8B-77623D8371CDQ24568048-D6C7B6A2-79FC-44F9-9BA6-19C9ABD98F39Q24599886-108666EE-31B8-4F5C-AF67-B7DD95552269Q24620685-2128E7C9-23CE-4347-95C6-122AC70FF0C6Q24624398-2367FFF0-FC3B-4C45-8FA4-9BE15593FC4EQ24635332-CD879CE9-1F28-4DBB-854C-B85627EC584DQ24647620-7872DF77-005D-4E91-9D4B-BD9AA092C43EQ24650785-8DA09B99-B8E3-4AF6-B641-DA133B39CD82Q24653006-DE69DA01-E6A0-45AD-A137-BAD0AC947427Q24653434-91F1A55D-A213-48A6-9B98-99EC641ACBEBQ24655964-0E9C0342-5C8E-4663-8168-B7E472E15AFFQ24669898-86E3446A-8796-4A98-8708-20BA77100B95Q24685868-44ABB901-7BC3-484E-B07F-58E9F9BB5F96Q26782868-027C9DD0-738B-4964-818F-B3CDC7FE3432Q28201685-532C2FCD-5466-42AC-9BC5-7A93A30EA787Q28207596-F1C091D2-905A-4D56-BF95-9D71BBA64FB0Q28215361-45F6D600-4121-4720-8FCE-64284F7D18E7Q28215995-020576BB-73DC-4B53-B992-96E0205F80ABQ28235210-24AE8BB0-CC4D-4139-A66B-8BB54F416C4AQ28237066-FE4E4456-09FC-4FAE-BAF5-AC2FE63511D2Q28242886-CFE80535-83FB-4709-B29F-37B305C02805Q28248800-8A0F02F4-32D1-481E-AEA7-F5B62974F7AFQ28260565-1801299E-61E7-4239-BC0C-F04EFC8CF223Q28260593-1DA5E4D2-F934-412C-8814-ABFC30177837Q28286610-492F85F7-FB23-49DB-90E7-F9944FA12912Q28290236-3AE36FC8-98D0-4C6A-A065-82DF5E9B6918Q28295554-A81683D9-1623-4ED1-A889-B6E4BCBA85AEQ28301547-D6E4DA52-3D96-44D9-A421-E7CC34B530C2Q28302226-5324A7AB-CB23-498D-9A6F-8CB4E93EAAF8Q28303965-12910431-8C3A-4774-AECE-D82F9B54174DQ28744143-575B52D4-E531-4D65-8638-D5A44B30A1CBQ30275382-E55EF54D-809B-4F1C-81BC-DA29789B7F76Q30278687-DAE656E6-B63A-4307-AF60-31CCCA236621Q30301228-797E9B38-7AB6-4117-B094-E2641F659971Q30404080-ABA715A0-A2B7-4AF8-9B99-BE97955F9FAEQ30433090-650DC2CB-EE26-4ABA-8490-D79E21E2D4BEQ30528279-63D4DB64-5D35-4195-8F49-25C8EC3E5428Q30638606-1F2EF33D-F1D4-4C69-A72F-B4189398DCCEQ31031931-BAFA3E0D-A7A7-4F26-B344-47AB794848C3Q33151135-570AEA86-28F2-4243-B3CD-BA1F1E3E2E6D
P50
name
Robert A Kyle
@ast
Robert A Kyle
@en
Robert A Kyle
@es
Robert A Kyle
@nl
type
label
Robert A Kyle
@ast
Robert A Kyle
@en
Robert A Kyle
@es
Robert A Kyle
@nl
prefLabel
Robert A Kyle
@ast
Robert A Kyle
@en
Robert A Kyle
@es
Robert A Kyle
@nl
P1006
P214
P1006
P214
P31
P734
P735
P7859
lccn-n79119380